Orphazyme A/S ORPHA-DK:Copenhagen Stock Exchange

RT Quote | Exchange | DKK
Last | 11:28 AM CET
76.50quote price arrow down-2.00 (-2.55%)
Volume
29,486
52 week range
62.40 - 85.90

...

Loading . . .

KEY STATS

  • Open78.40
  • Day High78.40
  • Day Low76.00
  • Prev Close78.50
  • 52 Week High85.90
  • 52 Week High Date01/25/21
  • 52 Week Low62.40
  • 52 Week Low Date01/07/21
  • Market Cap321.9M
  • Shares Out27.04M
  • 10 Day Average Volume136,927.3
  • Dividend-
  • Dividend Yield-
  • Beta2.09
  • 1 Year % Change-33.77

RATIOS/PROFITABILITY

  • EPS (TTM)-18.54
  • P/E (TTM)-4.13
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Orphazyme A/S News

There is no recent news for this security.

Latest ORPHA-DK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Orphazyme A/S, formerly Orphazyme ApS, is a Denmark-based company active within the biopharmaceutical industry. It develops new therapies for the treatment of a family of genetic disorders. The Company's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases. The...
Georges Gemayel Ph.D.
Chairman
Bo Hansen M.D. Ph.D.
Vice Chairman
Anders Fink Vadsholt
Chief Financial Officer
Address
Ole Maaloees Vej 3, Copenhagen N
Koebenhavn
2200
Denmark